ADAMS STREET PARTNERS LLC — 13F Holdings & Portfolio
CIK 1193586 · latest 13F-HR filed 2026-08-14
ADAMS STREET PARTNERS LLC manages $442.7M in 13F-reported U.S. long-equity assets across 4 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are BLLN (46.39%), RMNI (22.68%), CBRS (19.88%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 1 new position, exited 0, added to 2, and trimmed 0.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
STE 2700
CHICAGO, IL 60606-2807
$442.7M
Long-equity book
4
Distinct positions
2026-06-30
Filed 2026-08-14
+1 / −0 / ↑2 / ↓0
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- BillionToOne, Inc.$70.2M +52.0%
- Rimini Street, Inc.$23.1M +29.9%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | BillionToOne, Inc. | BLLN | 090168105 | $205.3M | 46.39% | 1,711,430 | SH |
| 2 | Rimini Street, Inc. | RMNI | 76674Q107 | $100.4M | 22.68% | 23,565,433 | SH |
| 3 | Cerebras Systems, Inc. | CBRS | 15675D103 | $88.0M | 19.88% | 398,144 | SH |
| 4 | Corvus Pharmaceuticals, Inc. | CRVS | 221015100 | $48.9M | 11.06% | 3,275,616 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $442.7M | 4 | 0001104659-26-096390 |
| 2026-03-31 | 2026-05-15 | $260.3M | 3 | 0001104659-26-062273 |
| 2025-12-31 | 2026-02-13 | $263.9M | 5 | 0001104659-26-014635 |
| 2025-09-30 | 2025-11-14 | $153.2M | 5 | 0001104659-25-111905 |